← Research analysis

Peptides

MOTS-c: a mitochondrial peptide with mouse metabolic data

Compound: MOTS-cEvidence base: Preclinical onlyUpdated: 2026-10-02Last reviewed: September 2026By: APEDRA editorial team

MOTS-c is a mitochondria-derived peptide shown to affect insulin sensitivity and exercise capacity in mice. Human studies are observational measurements of circulating levels, not intervention trials.

Key points

  • Key metabolic findings come from mouse models.
  • Human data correlate endogenous levels with exercise or age.
  • No controlled human trial of administered MOTS-c.
  • Products sold online under this name have not been independently verified; label identity and concentration cannot be assumed.

What the literature shows

Lee and colleagues identified MOTS-c and reported improved insulin sensitivity and reduced diet-induced obesity in mice.

Reynolds and colleagues reported exercise-induced increases in MOTS-c in humans and improved physical capacity in treated aged mice.

What remains unknown

  • Human pharmacokinetics, dose and safety are unknown.
  • Immune response to repeated injection.

Safety and monitoring implications

  • Animal exercise findings should not be read as human performance evidence.
  • Injection-related infection risks apply.

Cited literature

  1. 1.Lee C, Zeng J, Drew BG, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. Find on PubMed
  2. 2.Reynolds JC, Lai RW, Woodhead JST, et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. Find on PubMed

Community reports

Anecdotal — not scientific evidence

Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.

Editorial evidence status

Mixed

Community discussion of this compound is widespread, but no independently verified reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.

Buying MOTS-c in Australia: what to check first

APEDRA does not sell MOTS-c or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.

  • Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
  • Check independent review platforms, not only reviews hosted on the seller's own site.
  • Read the shipping, returns and refund policies before ordering.
  • Be wary of prices far below the market or exaggerated results claims.

Compare Australian vendors independently · how we assess suppliers

Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.

This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.